Top Markets
#1 MowCat MowCat +48.40%
#2 Bermuda Shorts Bermuda Shorts +26.48%
#3 Velvet Velvet +24.18%
#4 Biconomy Biconomy +21.78%
#5 Quack AI Quack AI +20.42%
#6 Derive Derive +17.43%
#7 Block Street Block Street +15.20%
#8 DUSK Network DUSK Network +14.39%
#9 Zerebro Zerebro +13.96%
#10 Palladium Network Palladium Network +13.60%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
GeneTether Therapeutics Inc. GeneTether Therapeutics Inc.

GeneTether Therapeutics Inc.

GTTX
Rangering i aksjer #34710
GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in... GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in genetic medicines. Its primary focus is the advancement of gene-editing therapies, aiming to significantly boost the effectiveness of current genomic modification techniques. The company's pipeline is dedicated to engineering genetic treatments for individuals suffering from rare, single-gene disorders affecting the kidneys and skin. Established in 2018, GeneTether Therapeutics Inc. is headquartered in Kelowna, Canada.
Aksjekurs
$0.10409799
Sist synkronisert: 2025-02-03
Markedsverdi
$5.07M
Endring (1 dag)
16.43%
Endring (1 år)
0.00%
Land
CA
Handel GeneTether Therapeutics Inc. (GTTX)

Kategori

Healthcare
P/B-forhold for GeneTether Therapeutics Inc. (GTTX)
P/B-forhold per 2026 TTM: 0
Ifølge GeneTether Therapeutics Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for GeneTether Therapeutics Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE